The GHRP Family: Same Receptor, Different Profiles
Growth hormone releasing peptides (GHRPs) are a class of synthetic peptides that stimulate growth hormone release by activating the GHS-R1a receptor (ghrelin/growth hormone secretagogue receptor) on the anterior pituitary gland. They work as the “trigger” that causes the pituitary to release stored GH — as opposed to GHRH analogs like CJC-1295, which tell the pituitary to produce and prepare GH for release.
There are four GHRPs worth knowing about: Ipamorelin, GHRP-2, GHRP-6, and Hexarelin. They all activate the same receptor, but they differ dramatically in selectivity — meaning how many other hormonal pathways they activate alongside GH release. This selectivity profile is what makes the choice between them so consequential.
GHRP-6 and Ipamorelin sit at opposite ends of the spectrum. GHRP-6 is the “dirty” GHRP — high GH output but significant cortisol, prolactin, and appetite stimulation. Ipamorelin is the “clean” GHRP — moderate GH output with virtually no off-target effects.
Head-to-Head Comparison
| Feature | Ipamorelin | GHRP-6 |
|---|---|---|
| Drug class | Growth hormone releasing peptide | Growth hormone releasing peptide |
| Receptor target | GHS-R1a (highly selective) | GHS-R1a (non-selective) |
| Route | Subcutaneous injection | Subcutaneous injection |
| Dose | 200-300 mcg per injection | 100-200 mcg per injection |
| Dosing frequency | 2-3x daily | 2-3x daily |
| Half-life | ~2 hours | ~20 minutes |
| GH release magnitude | Moderate | High (30-50% more than Ipamorelin) |
| GH release pattern | Sharp pulse | Sharp pulse (larger amplitude) |
| Cortisol elevation | None at standard doses | Significant (up to 50% increase) |
| Prolactin elevation | None at standard doses | Mild to moderate |
| ACTH elevation | None | Yes |
| Appetite stimulation | Minimal | Severe (strongest of all GHRPs) |
| Water retention | Mild | Moderate |
| Desensitization | Minimal (months of use before onset) | Moderate (noticeable at 8-12 weeks) |
| Insulin impact | Minimal | Mild worsening |
| Onset of GH peak | 15-30 minutes post-injection | 15-30 minutes post-injection |
| Best paired with | CJC-1295 (standard) | CJC-1295 (for maximum output) |
| Cost/month | $50-100 | $30-60 |
| Ideal for | Cutting, anti-aging, general wellness, clinical use | Bulking, appetite stimulation, maximum GH |
| Human data | Phase II trial data | Clinical studies |
Understanding the Selectivity Difference
Why Selectivity Matters
The GHS-R1a receptor is not isolated — it cross-talks with other hormonal pathways. When a GHRP activates the ghrelin receptor, it can also trigger:
- Cortisol release via ACTH stimulation from the pituitary
- Prolactin release from lactotroph cells in the pituitary
- Appetite signaling via hypothalamic ghrelin pathways
- Gastric motility via peripheral ghrelin receptor activation
A “selective” GHRP like Ipamorelin activates the receptor in a way that primarily triggers GH release with minimal cross-talk to these other pathways. A “non-selective” GHRP like GHRP-6 activates the receptor in a broader way that triggers all of these pathways simultaneously.
Ipamorelin: The Clean Profile
Ipamorelin was specifically designed for selectivity. Raun et al. (1998) published the key selectivity data in the European Journal of Endocrinology, demonstrating that Ipamorelin:
- Releases GH in a dose-dependent manner
- Does not release ACTH or cortisol at any dose tested (even at 10x the GH-releasing dose)
- Does not elevate prolactin at standard doses
- Has minimal effect on appetite signaling
- Does not produce the rapid desensitization seen with less selective GHRPs
This selectivity makes Ipamorelin the safest GHRP for long-term use, and the reason it is the standard GHRP prescribed by anti-aging clinics and used in the majority of GH peptide protocols.
GHRP-6: The Broad Activator
GHRP-6 was one of the first synthetic GHRPs developed. It activates the GHS-R1a receptor broadly, triggering multiple downstream pathways:
-
Cortisol: GHRP-6 at standard doses (100-200 mcg) produces cortisol elevations of 30-50% above baseline. Cortisol is catabolic (breaks down muscle tissue), promotes abdominal fat storage, suppresses immune function, and disrupts sleep when chronically elevated. For users whose primary goal is body composition, this cortisol elevation directly undermines the benefit of the increased GH.
-
Prolactin: GHRP-6 produces mild to moderate prolactin elevation. Chronically elevated prolactin can cause gynecomastia (male breast tissue), reduced libido, and mood changes. The prolactin elevation from GHRP-6 is generally manageable at standard doses but becomes a concern with long-term continuous use.
-
Appetite: GHRP-6 produces the most intense appetite stimulation of any GHRP — significantly more than GHRP-2 or MK-677. The hunger onset is rapid (20-30 minutes post-injection) and can be difficult to resist. This is mediated by the same ghrelin pathway that creates hunger before meals.
The Full GHRP Family Comparison
To put GHRP-6 and Ipamorelin in context, here is the complete GHRP family comparison:
| Feature | Ipamorelin | GHRP-2 | GHRP-6 | Hexarelin |
|---|---|---|---|---|
| GH release | Moderate | High | High | Highest |
| Selectivity | Highest (cleanest) | Moderate | Low | Lowest |
| Cortisol | None | Mild | Significant | Significant |
| Prolactin | None | Mild | Mild-moderate | Moderate-high |
| Appetite | Minimal | Moderate | Severe | Moderate |
| Desensitization | Very slow | Moderate | Moderate | Rapid (2-4 weeks) |
| Best for | Most users, cutting, anti-aging | Middle-ground GH boost | Bulking, appetite | Short-term max GH (limited use) |
| Recommended pairing | CJC-1295 (standard) | CJC-1295 | CJC-1295 | CJC-1295 (short cycles only) |
| Long-term viability | Excellent | Good (monitor prolactin) | Fair (cortisol concern) | Poor (desensitization) |
| Clinical adoption | Highest | Moderate | Low | Very low |
| Cost/month | $50-100 | $40-80 | $30-60 | $40-80 |
Why Hexarelin Deserves Mention But Not Recommendation
Hexarelin produces the highest raw GH output of any GHRP — approximately 2x the GH release of Ipamorelin. However, it rapidly desensitizes the GHS-R1a receptor, typically within 2-4 weeks of continuous use. After desensitization, GH output drops to baseline or below, and the receptor requires weeks to months of rest before responding normally again.
This makes Hexarelin impractical for the continuous protocols that produce meaningful body composition and anti-aging results. Its use is limited to short 2-week bursts followed by extended breaks — a protocol that most users find inconvenient and inferior to consistent Ipamorelin or GHRP-2 use.
Decision Framework: GHRP-6 vs Ipamorelin
Choose Ipamorelin When:
- You are cutting or in a caloric deficit. No appetite disruption means you can maintain your diet without fighting peptide-induced hunger.
- Body composition is the primary goal. No cortisol elevation means the GH you release actually gets used for fat oxidation and muscle protein synthesis instead of being partially offset by cortisol’s catabolic effects.
- You plan to run the protocol for 3+ months. Ipamorelin’s minimal desensitization and clean side effect profile make it suitable for extended use.
- Anti-aging or general wellness is the goal. Clinics prescribe Ipamorelin because of its safety profile for long-term optimization.
- You have any metabolic concerns. Prediabetes, insulin resistance, metabolic syndrome — Ipamorelin is the metabolically safest GHRP.
- This is your first GH peptide. Start with the cleanest option, then adjust if you want stronger output.
Choose GHRP-6 When:
- You are bulking and struggling to eat enough. GHRP-6’s appetite stimulation is the strongest available — it can add 500-1,000 calories/day to your intake through increased hunger alone.
- You are underweight or recovering from illness. The appetite and GH stimulation combination supports weight gain and recovery.
- Maximum GH output is the priority. If you specifically need the highest possible GH spike per injection and can tolerate the cortisol and appetite effects.
- You are running a short cycle (4-6 weeks). The cortisol and desensitization concerns are less relevant for short-duration use.
- Cost is the primary constraint. GHRP-6 is typically 30-50% cheaper than Ipamorelin.
Choose GHRP-2 When:
- You want more GH than Ipamorelin but can’t tolerate GHRP-6’s hunger. GHRP-2 is the Goldilocks option — stronger than Ipamorelin, milder than GHRP-6.
- You want moderate appetite stimulation. GHRP-2’s hunger effect is noticeable but manageable — not the overwhelming urge produced by GHRP-6.
- You are comfortable with mild cortisol and prolactin elevation. GHRP-2’s off-target effects are present but manageable with monitoring.
Practical Dosing Protocols
Standard Ipamorelin Protocol (with CJC-1295)
| Parameter | Value |
|---|---|
| Ipamorelin dose | 200-300 mcg per injection |
| CJC-1295 dose | 100 mcg per injection |
| Frequency | 2-3x daily |
| Timing | Morning fasted, post-workout, and/or 30 min before sleep |
| Cycle length | 8-16 weeks |
| Time off | 4 weeks minimum between cycles |
| Food timing | Inject on empty stomach; wait 20-30 min before eating (food-derived insulin blunts GH release) |
Standard GHRP-6 Protocol (with CJC-1295)
| Parameter | Value |
|---|---|
| GHRP-6 dose | 100-200 mcg per injection |
| CJC-1295 dose | 100 mcg per injection |
| Frequency | 2-3x daily |
| Timing | Morning fasted, post-workout, and/or 30 min before sleep |
| Cycle length | 4-8 weeks (shorter than Ipamorelin due to desensitization and cortisol) |
| Time off | 4-6 weeks between cycles |
| Food timing | Inject on empty stomach; have a meal prepared — you will be hungry within 30 minutes |
Key Dosing Notes
Fasted injection is critical for both. GH release is significantly blunted when insulin is elevated. Inject at least 2 hours after your last meal, and wait 20-30 minutes after injection before eating. The pre-sleep dose is naturally fasted for most people (2+ hours after dinner).
GHRP-6 timing strategy: Many GHRP-6 users strategically time their injections 30 minutes before their largest meals. The appetite spike hits right when the meal is served, turning the side effect into a feature. This works well for bulking protocols.
The fasting exception for GHRP-6: Some users find GHRP-6’s hunger so intense that they cannot wait the recommended 20-30 minutes post-injection before eating. In practice, eating 15 minutes post-injection (after the GH pulse has initiated) is an acceptable compromise that captures most of the GH release while satisfying the hunger.
Side Effect Management
Ipamorelin Side Effects
Ipamorelin’s side effect profile is remarkably mild:
| Side Effect | Frequency | Management |
|---|---|---|
| Injection-site redness | Common | Normal; rotate sites |
| Mild headache | Occasional (first week) | Usually resolves; reduce dose temporarily if persistent |
| Water retention (mild) | Common | Typically resolves after 1-2 weeks of adaptation |
| Transient dizziness | Rare | Slow positional changes; usually first-dose only |
GHRP-6 Side Effects
| Side Effect | Frequency | Management |
|---|---|---|
| Intense hunger | Very common (15-30 min post-injection) | Time injections before planned meals; have food prepared |
| Cortisol elevation | Expected at all doses | Monitor AM cortisol if running 8+ weeks; limit to 4-8 week cycles |
| Water retention | Common | Moderate sodium; increase water intake |
| Injection-site redness | Common | Normal; rotate sites |
| Prolactin elevation | Occasional | Monitor if running extended cycles; rarely clinically significant |
| Lightheadedness | Occasional | More common than with Ipamorelin; inject while seated |
| Numbness/tingling in extremities | Uncommon | GH-related; typically transient; reduce dose |
When Cortisol Becomes a Problem
If you choose GHRP-6, watch for signs of chronic cortisol elevation:
- Difficulty sleeping (especially falling asleep)
- Increased abdominal fat despite caloric control
- Mood changes (irritability, anxiety)
- Reduced recovery from workouts
- Increased blood pressure
If these appear, reduce GHRP-6 dose, reduce frequency to 1-2x daily, or switch to Ipamorelin. A morning cortisol blood test confirms whether levels are clinically elevated.
Bloodwork Monitoring
| Marker | Both GHRPs | GHRP-6 Specific |
|---|---|---|
| IGF-1 | Baseline + 8 weeks (confirms GH axis activation) | Same |
| Fasting glucose | Baseline + 8 weeks | Monthly (GHRP-6 has mild insulin impact) |
| AM cortisol | Optional for Ipamorelin | Baseline + 8 weeks (mandatory) |
| Prolactin | Optional for Ipamorelin | Baseline + 8 weeks (if running 8+ weeks) |
| CBC | Baseline | Baseline |
Summary: The Decision Simplified
| Your Situation | Choose |
|---|---|
| First time using a GHRP | Ipamorelin — cleanest starting point |
| Cutting or caloric deficit | Ipamorelin — no appetite disruption or cortisol |
| Bulking or struggling to eat | GHRP-6 — appetite stimulation is the feature |
| Anti-aging / longevity protocol | Ipamorelin — safest for long-term use |
| Maximum short-term GH output | GHRP-6 — higher peak GH per injection |
| Running with CJC-1295 (standard) | Ipamorelin — the gold standard pairing |
| Budget-constrained | GHRP-6 — 30-50% cheaper |
| Underweight or cachexic | GHRP-6 — appetite and GH combination |
| Want a middle ground | GHRP-2 — splits the difference |
Related Protocols
- Ipamorelin Protocol — full dosing and cycle guide
- CJC-1295 Protocol — the GHRH analog that pairs with all GHRPs
- MK-677 Protocol — oral GH secretagogue alternative
- GH Peptides Compared — all six GH peptides head-to-head
- Growth Hormone Stack — CJC-1295 + Ipamorelin combination protocol
- CJC-1295 vs MK-677 — injectable vs oral GH peptide comparison
- Reconstitution Calculator — exact dosing math for GHRPs
Frequently Asked Questions
Is GHRP-6 stronger than Ipamorelin? +
Yes. GHRP-6 produces a larger peak GH release than Ipamorelin at equivalent doses — roughly 30-50% more GH per injection in comparative studies. However, this comes with significant cortisol elevation (up to 50% increase), prolactin elevation, and intense appetite stimulation. Ipamorelin produces less raw GH output but is far cleaner — no cortisol, no prolactin, minimal appetite impact. The question is whether the extra GH is worth the additional side effects.
Does GHRP-6 make you hungry? +
Extremely. GHRP-6 produces the most intense appetite stimulation of any GHRP — some users describe it as an almost uncontrollable urge to eat within 20-30 minutes of injection. This happens because GHRP-6 strongly activates the ghrelin receptor, which is the body's primary hunger signal. For bulking or weight gain, this is a feature. For cutting, body composition goals, or anyone with a history of binge eating, it is a serious contraindication.
Can I use GHRP-6 for cutting or fat loss? +
GHRP-6 is a poor choice for cutting. The intense appetite stimulation makes caloric deficit maintenance extremely difficult. The cortisol elevation can promote abdominal fat storage and muscle catabolism — the opposite of what you want when cutting. Ipamorelin is the standard GHRP for cutting because it has minimal appetite impact and no cortisol elevation. If you want GH support during a cut, use Ipamorelin + CJC-1295.
Which GHRP should I pair with CJC-1295? +
Ipamorelin is the standard pairing for most users. It provides clean GH release without cortisol, prolactin, or appetite disruption. GHRP-2 is the middle-ground option — stronger GH release than Ipamorelin with moderate side effects. GHRP-6 is for users specifically seeking maximum GH output and appetite stimulation (bulking, underweight individuals). The CJC-1295 + Ipamorelin combination is the most widely used and clinically prescribed GH peptide stack.
What about GHRP-2 and Hexarelin — how do they compare? +
GHRP-2 sits between Ipamorelin and GHRP-6 — stronger GH release than Ipamorelin, moderate appetite stimulation, mild cortisol and prolactin elevation. It is a reasonable middle-ground choice. Hexarelin is the most potent GHRP by raw GH output but has the most side effects (significant cortisol, prolactin, and rapid receptor desensitization within 2-4 weeks). Hexarelin is rarely recommended because the desensitization issue limits its practical use to short cycles.